Loading resource…

Dr. Frank Post
The appendix provides detailed supplementary information for the study titled 'Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial)'. It includes various tables and figures that present clinical site information, viral load data, adverse events, and statistical analysis plans. This document is intended to support the findings of the main trial publication by offering comprehensive data that was peer-reviewed and is relevant for understanding the trial's outcomes.
No account needed